Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Mancuso

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Therapeutic Innovation & Regulatory Science|October 7, 2023
Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved DropoutsShuai Wang, Robert Frederich, James P Mancuso
BMC Medical Research Methodology|February 21, 2025
Comprehensive implementations of multiple imputation using retrieved dropouts for continuous endpointsShuai Wang, Pamela F Schwartz, James P Mancuso
Biometrics|June 20, 2002
Age-adjusted exact trend tests in the event of rare occurrencesJessica Y Mancuso, Hongshik Ahn, James J Chen, et al.
Annals of Internal Medicine|February 18, 2009
Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trialAndres G Digenio, James P Mancuso, Robert A Gerber, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 7, 2020
Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled TrialsShrita Patel, Anne Hickman, Robert Frederich, et al.
Current Medical Research and Opinion|April 24, 2020
Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitusJie Liu, Lisa Tarasenko, Annpey Pong, et al.
Current Medical Research and Opinion|April 24, 2020
Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitusJie Liu, Lisa Tarasenko, Annpey Pong, et al.
Diabetes & Vascular Disease Research|May 14, 2019
Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studiesJie Liu, Lisa Tarasenko, Steven G Terra, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 10, 2018
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized StudySam Miller, Tania Krumins, Haojin Zhou, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 22, 2017
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized StudyGeorge Grunberger, Sarah Camp, Jeremy Johnson, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Therapeutic Innovation & Regulatory Science|October 7, 2023
Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved DropoutsShuai Wang, Robert Frederich, James P Mancuso
BMC Medical Research Methodology|February 21, 2025
Comprehensive implementations of multiple imputation using retrieved dropouts for continuous endpointsShuai Wang, Pamela F Schwartz, James P Mancuso
Biometrics|June 20, 2002
Age-adjusted exact trend tests in the event of rare occurrencesJessica Y Mancuso, Hongshik Ahn, James J Chen, et al.
Annals of Internal Medicine|February 18, 2009
Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trialAndres G Digenio, James P Mancuso, Robert A Gerber, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 7, 2020
Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled TrialsShrita Patel, Anne Hickman, Robert Frederich, et al.
Current Medical Research and Opinion|April 24, 2020
Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitusJie Liu, Lisa Tarasenko, Annpey Pong, et al.
Current Medical Research and Opinion|April 24, 2020
Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitusJie Liu, Lisa Tarasenko, Annpey Pong, et al.
Diabetes & Vascular Disease Research|May 14, 2019
Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studiesJie Liu, Lisa Tarasenko, Steven G Terra, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 10, 2018
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized StudySam Miller, Tania Krumins, Haojin Zhou, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 22, 2017
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized StudyGeorge Grunberger, Sarah Camp, Jeremy Johnson, et al.
Pageof 4